Podcasts about ohsu

Dr. Luiz E. Bertassoni is the founding director of the Knight Cancer Precision Biofabrication Hub and Professor in the Division of Oncological Sciences at the Knight Cancer Institute, where he is also co-section head for Discovery and Translational Oncology. He is also faculty in the Department of Biomedical Engineering, the Cancer Early Detection Advanced Research (CEDAR) Center, and the Oregon Health and Sciences University (OHSU) School of Dentistry. Luiz is co-founder of 2 biotech spin-off companies which resulted from his work on cancer research and regenerative medicine: he is Co-Founder and Chief Technology Officer of HuMarrow and Co-Founder and Chief Medical Officer of RegendoDent. Outside of science, Luiz is a big fan of surfing, and he enjoyed frequent trips to the beach while completing his PhD in Sydney, Australia, and a postdoctoral fellowship in San Francisco, California. In addition to spending time in the water, Luiz loves music. He is a singer-songwriter who plays various instruments, including guitar, drums, bass, and piano. In his research, Luiz applies engineering tools to biology to build human tissues in the lab. The goal of Luiz's lab is to create new models to better understand cancers and develop methods to regenerate lost or damaged tissues. Luiz was awarded his Doctor of Dental Surgery (DDS) degree from the Pontifical Catholic University of Parana in Brazil. Afterwards, he conducted postdoctoral research at the University of California, San Francisco. He then enrolled in a graduate program and received his PhD in Biomaterials from the University of Sydney. Next he accepted a postdoctoral fellowship in Harvard Medical School and MIT's joint program in Health Sciences and Technology. He served on the faculty at the University of Sydney before joining the faculty at OHSU in 2015. His work on vascular bioprinting was listed in the top 100 research discoveries by Discover Magazine, and he has received over 30 national and international research awards, including the Medical Research Foundation New Investigator award, the Silver Family Faculty Innovation award, and many others. In this interview, Luiz shares more about his life and science.

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, AppleTV or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Nicole: Willingness to take bold leaps and embrace the unknown.Imagine a world where cancer is as treatable as the flu. That's the vision Nicole Paulk, the founder and CEO of Siren Biotechnology, is working tirelessly to bring to life. Driven by groundbreaking science, Nicole's company is on the brink of launching clinical trials for a revolutionary cancer treatment.Nicole's work leverages engineered viruses—those that don't make you sick—to deliver genetic medicines directly to cancer cells. These “good viruses” act as a delivery system for anti-tumor drugs, targeting difficult-to-treat cancers like recurrent high-grade gliomas, a fatal brain cancer. “We started to see data that looked really promising in this space,” Nicole explained, adding, “We felt a moral obligation to go after this cancer where there's just this huge unmet need.”Siren Biotechnology's approach is designed to have broad applications. Unlike treatments that target specific genetic mutations, their method has the potential to work on various tumor types. Nicole describes it as using viruses like a “little FedEx delivery truck” that can be engineered to deliver medicine precisely where it's needed in the body.This innovation didn't happen overnight. Nicole, a former professor of virology at UCSF, took the bold step of leaving academia to launch Siren Biotechnology. “I decided to resign from my faculty position and go be the founder and CEO just because I was so excited about the data and what we had so far,” she shared.In addition to traditional venture capital funding, Siren Biotechnology is inviting the public to invest through a regulated investment crowdfunding campaign. This unique opportunity allows patients, families, and supporters touched by cancer to be part of their journey. “We wanted to bring patients and their families onto our cap table,” Nicole said. “It's a way to involve them in the conversation much earlier.”Siren Biotechnology's work could redefine cancer care and inspire a new model for patient-centered innovation. With clinical trials just months away, the future looks brighter for those battling cancer—and for all of us who dream of a world where cancer is no longer a death sentence.tl;dr:Nicole Paulk's Siren Biotechnology transforms viruses into targeted cancer therapies with universal potential.The company focuses on recurrent high-grade gliomas, a fatal brain cancer with no standard treatment.Nicole left academia to lead Siren, leveraging her groundbreaking virology research to launch the company.Siren's unique crowdfunding campaign lets patients and families invest in the fight against cancer.Nicole's superpower, fearless innovation, drives her bold mission to revolutionize cancer care.How to Develop Fearless Innovation As a SuperpowerNicole's superpower is her willingness to take bold leaps and embrace the unknown. After spending nearly two decades building her academic career, Nicole left her position as a virology professor at UCSF to start Siren Biotechnology. She explained, “I feel like my superpower is just kind of being willing to jump off the cliff without a parachute and be like, we're going to figure it out. We're going to make it work.”Nicole exemplified fearless innovation when her research led to a groundbreaking discovery about the biology of a virus, one that required rewriting existing textbooks. Initially met with skepticism, her work was later validated and became a foundation for Siren Biotechnology's cancer treatment. This pivotal moment highlights Nicole's courage to challenge conventional knowledge and pursue transformative ideas.Tips for Developing This Superpower:Be willing to question conventional wisdom and explore new paths.Take calculated risks, even if it means stepping away from a well-defined career path.Embrace discomfort and uncertainty as a necessary part of innovation.Engage others by communicating your vision in relatable and accessible ways.By following Nicole's example and advice, you can make fearless innovation a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileNicole Paulk (she/her):CEO, Founder, President, Siren BiotechnologyAbout Siren Biotechnology: We are combining two transformative therapeutic technologies – AAV gene therapy and cytokine immunotherapy – into a single, reimagined modality that overcomes key challenges and redefines how we destroy tumor cells and elicit anti-tumor immunity.This is the first AAV gene therapy drug product that can be made once and used in numerous indications – a huge leap forward for the field. This drastically reduces clinical development times, manufacturing timelines, and capital needs for each clinical trial. Most importantly, ‘universal' means countless solid tumor cancer patients – regardless of tumor type or mutations – may benefit from this breakthrough approach.Website: sirenbiotechnology.comX/Twitter Handle: @SirenBioCompany Facebook Page: facebook.com/SirenBiotechnologyOther URL: wefunder.com/siren.biotechnologyBiographical Information: Dr. Nicole Paulk is the CEO, Founder, and President of Siren Biotechnology and has dedicated her career to advancing the field of gene therapy. With nearly two decades of expertise, Nicole has been at the forefront of developing cutting-edge advances to propel the field of gene therapy forward for a wide range of diseases.Before founding Siren, Nicole held various leadership positions in academia and industry and most notably was an Assistant Adj Professor of AAV Gene Therapy in the UCSF Department of Biochemistry & Biophysics before leaving to found Siren. Nicole has a B.S. in Medical Microbiology, a Ph.D. in Viral Gene Therapy and Regenerative Medicine from OHSU, and completed her Postdoctoral Fellowship and Instructorship in Human Gene Therapy at Stanford University prior to starting her lab at UCSF. Nicole is a pioneer in the development of next-generation AAV platforms for gene repair, gene transfer and gene editing, directed evolution for novel engineered capsid evolution, and comparative multi-omic approaches to interrogate translational AAV biology.Nicole is a renowned expert in gene therapy and has consulted extensively for big pharma, written draft CMC guidance for the FDA, and sits on the Scientific Advisory Boards for Sarepta, Astellas, Metagenomi, Dyno Therapeutics, CEVEC, GRO Biosciences, Excision BioTherapeutics, WhiteLab Genomics, Johns Hopkins Gene Therapy Initiative, the Gene Therapy for Rare Disorders Searchlight Program, and several stealth startups. She has been quoted in The Wall Street Journal, The Economist, The Boston Globe, Endpoints, STAT, Phacilitate, GEN, BioPharma Dive, Evaluate Vantage, SF Business Times, WIRED, Drug Discovery World, MIT Tech Review, C&EN, and more. She sits on the Scientific Editorial Boards of the journals Gene Therapy, Human Gene Therapy, and Biopharma International Gene Therapy. She is the Chair of the American Society of Gene and Cell Therapy (ASGCT) Translational Science Committee, and a member of the ASGCT Cancer Cell and Gene Therapy Committee and the Biocom California Cell and Gene Therapy Committee. She has invented numerous AAV gene therapy technologies that have been shared or licensed to dozens of gene therapy companies and nonprofit groups working in rare diseases.Outside of work, you can find Nicole adventure traveling (think whitewater rafting meets backcountry trekking), snowboarding, planning elaborate Halloween parties complete with animatronics and ghoulish menus, tending her vegetable garden, and obsessing over the latest wearable gadgets. If you're trying to track her down at a conference and can't find her, it's because she snuck off to an oyster bar.X/Twitter Handle: @Nicole_PaulkLinkedin: linkedin.com/in/nicolepaulkInstagram Handle: @sirenbioSupport Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include FundingHope, Kingscrowd and Crowdfunding Made Simple. Learn more about advertising with us here.Max-Impact MembersThe following Max-Impact Members provide valuable financial support:Carol Fineagan, Independent Consultant | Lory Moore, Lory Moore Law | Marcia Brinton, High Desert Gear | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Ralf Mandt, Next Pitch | Scott Thorpe, Philanthropist | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.Impact Cherub Club Meeting hosted by The Super Crowd, Inc., a public benefit corporation, on June 17, 2025, at 1:00 PM Eastern. Each month, the Club meets to review new offerings for investment consideration and to conduct due diligence on previously screened deals. To join the Impact Cherub Club, become an Impact Member of the SuperCrowd.SuperCrowdHour, June 18, 2025, at 12:00 PM Eastern. Jason Fishman, Co-Founder and CEO of Digital Niche Agency (DNA), will lead a session on "How to Spin $1 of Advertising into $10!" He'll reveal proven strategies and marketing insights drawn from years of experience helping successful crowdfunding campaigns. Whether you're a founder planning a raise or a supporter of innovative startups, you'll gain actionable tips to boost visibility, drive engagement, and hit your funding goals. Don't miss it!Join us on June 25, 2025, at 8:00 PM Eastern for the Superpowers for Good Live Pitch—streaming on e360tv, where purpose-driven founders take the virtual stage to present their active Regulation Crowdfunding campaigns to a national audience of investors and changemakers. Selected startups are chosen for their commitment to community, alignment with NC3's Community Capital Principles, and their drive to create real-world impact. Thanks to sponsors DNA and DealMaker, this event is free to watch and amplifies the voices of underrepresented and mission-aligned entrepreneurs. Don't miss this inspiring evening where capital meets purpose—tune in to discover and support the next wave of impact-driven innovation.SuperCrowd25, August 21st and 22nd: This two-day virtual event is an annual tradition but with big upgrades for 2025! We'll be streaming live across the web and on TV via e360tv. Soon, we'll open a process for nominating speakers. Check back!Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.Devin Thorpe is featured in a free virtual masterclass series hosted by Irina Portnova titled Break Free, Elevate Your Money Mindset & Call In Overflow, focused on transforming your relationship with money through personal stories and practical insights. June 8-21, 2025.Join Dorian Dickinson, founder & CEO of FundingHope, for Startup.com's monthly crowdfunding workshop, where he'll dive into strategies for successfully raising capital through investment crowdfunding. June 24 at noon Eastern. Regulated Investment Crowdfunding Summit 2025, Crowdfunding Professional Association, Washington DC, October 21-22, 2025.Call for community action:Please show your support for a tax credit for investments made via Regulation Crowdfunding, benefiting both the investors and the small businesses that receive the investments. Learn more here.If you would like to submit an event for us to share with the 9,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

Melissa Murphy, MD, Infectious Disease StaffPhysician/HIV Lead Clinician, Portland VA Medical Center; Associate Professor of Clinical Medicine, OHSU; Consultant, Mountain West AIDS Education Training CenterCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/Kwq9cDjFP5 (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1  creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: June 10, 2025End Date: June 10, 2026

Melissa Murphy, MD, Infectious Disease StaffPhysician/HIV Lead Clinician, Portland VA Medical Center; Associate Professor of Clinical Medicine, OHSU; Consultant, Mountain West AIDS Education Training CenterCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/Kwq9cDjFP5 (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1  creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: June 10, 2025End Date: June 10, 2026

Welcome back to our series on AI for the clinician! Large language models, like ChatGPT, have been taking the world by storm, and healthcare is no exception to that rule – your institution may already be using them! In this episode we'll tackle the fundamentals of how they work and their applications and limitations to keep you up to date on this fast-moving, exciting technology. Hosts: Ayman Ali, MD Ayman Ali is a Behind the Knife fellow and general surgery PGY-3 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery. Ruchi Thanawala, MD: @Ruchi_TJ Ruchi Thanawala is an Assistant Professor of Informatics and Thoracic Surgery at Oregon Health and Science University (OHSU) and founder of Firefly, an AI-driven platform that is built for competency-based medical education. In addition, she directs the Surgical Data and Decision Sciences Lab for the Department of Surgery at OHSU.  Phillip Jenkins, MD: @PhilJenkinsMD Phil Jenkins is a general surgery PGY-3 at Oregon Health and Science University and a National Library of Medicine Post-Doctoral fellow pursuing a master's in clinical informatics. Steven Bedrick, PhD: @stevenbedrick Steven Bedrick is a machine learning researcher and an Associate Professor in Oregon Health and Science University's Department of Medical Informatics and Clinical Epidemiology. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Welcome to our new series – the AI Journal Club! In this series, we'll cover some interesting studies and evidence-based applications of artificial intelligence in surgery in a case-based format. Surely AI can find a DVT by now … or can it? Stay tuned and find out! Hosts: - Ayman Ali, MD Ayman Ali is a Behind the Knife fellow and general surgery PGY-3 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery. - Ruchi Thanawala, MD: @Ruchi_TJ Ruchi Thanawala is an Assistant Professor of Informatics and Thoracic Surgery at Oregon Health and Science University (OHSU) and founder of Firefly, an AI-driven platform that is built for competency-based medical education. In addition, she directs the Surgical Data and Decision Sciences Lab for the Department of Surgery at OHSU.  - Marisa Sewell, MD: @MarisaSewell Marisa Sewell is a general surgery PGY-4 at Oregon Health and Science University.  Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

CTX is a rare metabolic disease that can cause seizures, developmental delays, and intellectual disability. Now, a diagnostic test that can detect the condition early is available, and a treatment that can prevent the disease's serious effects has won regulatory approval. We spoke to Bart Duell, professor of medicine at Oregon Health Sciences University, about CTX, the role OHSU played in developing a diagnostic and advancing a treatment for CTX; and the critical interplay between academic medical centers, patient advocates, and drug developers to address the needs of people with rare diseases.

An interview with Shannon Droning, Consumer and Specialty Market President of Providence Health Plan, Dr. Abby Khan, OHSU cardiologist, Dr. Amit Kansara, Providence neurologist, and Matthew Kampfe, Brain Rehab Network President. All are volunteers with the American Heart Association. We discuss heart disease and stroke causes and prevention and talk about the AHA Heart and Stroke Walks in Vancouver and Portland.

 On Monday, Oregon Health and Science University and Legacy Health announced they are mutually walking away from an effort to combine the two healthcare organizations. The merger was first announced last August, when OHSU agreed to acquire 8 hospitals, $3 billion in assets and promised a whopping $1 billion in upgrades to Legacy facilities. The merger garnered scrutiny from a citizen review committee and public comments have reflected opposition to the deal. Amelia Templeton is OPB’s Healthcare reporter and has been following this story. She joins with the latest.

Join Elevated GP: www.theelevatedgp.com Free Class II Masterclass - Click Here to Join Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Dr. Stanley Liu (“Leo”) received his undergraduate education from Stanford University. He completed DDS and MD degrees, with General Surgery internship and Oral & Maxillofacial Surgery residency, from the University of California – San Francisco (UCSF). After Sleep Surgery Fellowship at Stanford Medical School in 2014, he was appointed faculty in the Department of Otolaryngology until 2023. He rose to the rank of Associate Professor, and Director of the Sleep Surgery Fellowship. Concurrently, he was a Preceptor of the Oculoplastic Surgery Fellowship and held a courtesy appointment to the Division of Plastic & Reconstructive Surgery.  In February 2024, he joined Nova Southeastern University as the Chair of the Department of Oral & Maxillofacial Surgery, and Assistant Dean of Hospital Affairs. Dr. Liu is a Fellow of the American College of Surgeons (FACS), and the American College of Oral & Maxillofacial Surgeons. He has been a Howard Hughes Medical Institute (HHMI) Scholar, and Stanford Biodesign Faculty Fellow. He serves on the board or executive positions of the California Sleep Society (CSS), American Academy of Physiologic Medicine & Dentistry (AAPMD), and the World Dentofacial Sleep Society (WDSS). He is a consultant member in the sleep section of the American Academy of Otolaryngology – Head & Neck Surgery (AAO-HNS). Dr. Liu's clinical and research focus are on surgical approaches to obstructive sleep apnea. With his surgical mentor and sleep surgery pioneer, Dr. Robert Riley, the Stanford Sleep Surgery approach was updated to integrate drug-induced sleep endoscopy (DISE), nasal surgery including maxillary expansion (DOME), pharyngeal surgery (UPPP), hypoglossal nerve stimulation (HGNS), and maxillomandibular advancement (MMA).  His bibliography lists over 90 journal articles and 20 book chapters. He has been a Grand Rounds speaker at academic programs including UCSF, Northwestern, OHSU, LSU, and Stanford. He has been a Keynote Speaker for preeminent sleep and surgery meetings, including the 33rd SLEEP in 2019, and World Sleep in 2023.

  Join Elevated GP: www.theelevatedgp.com Free Class II Masterclass - Click Here to Join Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Dr. Stanley Liu (“Leo”) received his undergraduate education from Stanford University. He completed DDS and MD degrees, with General Surgery internship and Oral & Maxillofacial Surgery residency, from the University of California – San Francisco (UCSF). After Sleep Surgery Fellowship at Stanford Medical School in 2014, he was appointed faculty in the Department of Otolaryngology until 2023. He rose to the rank of Associate Professor, and Director of the Sleep Surgery Fellowship. Concurrently, he was a Preceptor of the Oculoplastic Surgery Fellowship and held a courtesy appointment to the Division of Plastic & Reconstructive Surgery.  In February 2024, he joined Nova Southeastern University as the Chair of the Department of Oral & Maxillofacial Surgery, and Assistant Dean of Hospital Affairs. Dr. Liu is a Fellow of the American College of Surgeons (FACS), and the American College of Oral & Maxillofacial Surgeons. He has been a Howard Hughes Medical Institute (HHMI) Scholar, and Stanford Biodesign Faculty Fellow. He serves on the board or executive positions of the California Sleep Society (CSS), American Academy of Physiologic Medicine & Dentistry (AAPMD), and the World Dentofacial Sleep Society (WDSS). He is a consultant member in the sleep section of the American Academy of Otolaryngology – Head & Neck Surgery (AAO-HNS). Dr. Liu's clinical and research focus are on surgical approaches to obstructive sleep apnea. With his surgical mentor and sleep surgery pioneer, Dr. Robert Riley, the Stanford Sleep Surgery approach was updated to integrate drug-induced sleep endoscopy (DISE), nasal surgery including maxillary expansion (DOME), pharyngeal surgery (UPPP), hypoglossal nerve stimulation (HGNS), and maxillomandibular advancement (MMA).  His bibliography lists over 90 journal articles and 20 book chapters. He has been a Grand Rounds speaker at academic programs including UCSF, Northwestern, OHSU, LSU, and Stanford. He has been a Keynote Speaker for preeminent sleep and surgery meetings, including the 33rd SLEEP in 2019, and World Sleep in 2023.

Oregon Health & Science University began its Long COVID-19 clinic in 2021, a year into the pandemic as the first vaccines were just becoming widely available. We talked with doctors in the clinic in 2022, and we wanted to check back in to see what clinicians have learned after treating thousands of long COVID patients. Aluko Hope is a pulmonologist, critical care doctor and the medical director of OHSU’s Long COVID-19 program. Jen Arnold is a lead nurse with the program. They both join us to tell us what they’ve learned about caring for patients with long COVID in the last four years and what they hope to learn more about from the research that’s currently underway.

SIIMCast takes a detour from its usual deep dives into imaging informatics to explore the quirky, vibrant city of Portland, Oregon—host of the 2025 SIIM Annual Meeting! Join us as we chat with Portland-based radiologist Dr. Neel Patel and SIIMCast co-founder Dr. Prasanth Prasanna, who doubles as both host and local guide. From legendary donuts to iconic bookstores, scenic hikes to top-notch pizza, and even whiskey libraries, we cover everything you need to know to make the most of your trip. Plus, we touch on Portland's growing role in radiology and informatics, including insights into OHSU, PACS transitions, and the future of AI in workflow optimization. Whether you're attending SIIM 2025 or just curious about Portland, this episode has something for everyone. Tune in for the ultimate Portland primer—no raincoat required! SIIM25 Registration and Details: https://annualmeeting.siim.org/

But will it be a home run? The Portland Diamond Project has so far struck out on its years-long efforts to bring Major League Baseball to Portland. But now they've got a new site on the South Waterfront, fresh energy from city leaders and a pitch to the Oregon Legislature, not to mention swoon-y renderings of a new stadium along the Willamette. Sports columnist Bill Oram and ECONorthwest economist Mike Wilkerson join Beat Check with The Oregonian to make sense of the numbers behind the proposal, the unknowns (who is behind that ownership group?) and what comes next. Wilkerson, a consultant to the Portland Diamond Project, says building a new stadium downtown could be a game-changer for Portland, the city that he recently and regretfully said was on the verge of a “doom loop” thanks to downward trends in population growth, the commercial real estate market and more. Stay tuned until the end of the episode to hear Oram and Wilkerson make it very clear where their own personal baseball allegiances land. Related coverage: Is a picture worth almost a billion dollars?OHSU responds to South Waterfront ballpark proposalEconomist warns of Portland ‘doom loop' Subscribe to Beat Check anywhere you listen to podcasts to get new episodes each week. You can support local journalism by becoming a subscriber to The Oregonian/OregonLive. Explore more of our podcasts and sign up to get newsletters for the latest news and top stories. Learn more about your ad choices. Visit megaphone.fm/adchoices

An estimated 650,000 adults in Bangladesh suffer from blindness, according to researchers. At the end of November, Oregon Health & Science University ophthalmologist Beth Edmunds traveled to the country to teach local doctors a minimally-invasive operation for adults and children with glaucoma. She joins us to share what she took away from her time volunteering and what it was like operating in the world’s only flying teaching hospital. 

Federal workforce layoffs, funding freezes, and internet beef between two Pacific Northwest mountains are on the table for today's midweek roundup. There's also news from OHSU about a new early-detection test for pancreatic cancer and comments from our listener mailbag. Joining host Claudia Meza on this midweek roundup is our very own senior producer, Giulia Fiaoni. Discussed in Today's Episode:  Mass Layoffs at Bonneville Power Administration Raise Concerns About Reliability of Power Grid [KGW] Oregon Senators Call for Federal Firefighters To Be Exempt From Hiring Freeze [OPB] OHSU Researchers Develop Test for Earlier Detection of Pancreatic Cancer [Wilamette Week] Court Pause on Trump Cuts to Medical Research Funds Is Expanded Nationwide [New York Times]  Become a member of City Cast Portland today! Get all the details and sign up here. Who would you like to hear on City Cast Portland? Shoot us an email at portland@citycast.fm, or leave us a voicemail at 503-208-5448. Want more Portland news? Then make sure to sign up for our morning newsletter, Hey Portland, and be sure to follow us on Instagram.  Looking to advertise on City Cast Portland? Check out our options for podcast and newsletter ads at citycast.fm/advertise. Learn more about the sponsors of this February 19th episode: Babbel - Get up to 60% off at Babbel.com/CITYCAST Treefort Music Fest Portland Jazz Festival Learn more about your ad choices. Visit megaphone.fm/adchoices

Oregon Health & Science University has been facing a series of mounting challenges in recent months, including its proposed merger with Legacy Health, which is being reviewed by the Oregon Health Authority. If approved, OHSU would control five of the six hospitals in Multnomah County, according to a report issued by OHA last November.  OHSU has also had to contend with the departure of prominent executives such as the interim head of its health unit last month, and Dr. Brian Druker, a world renowned cancer researcher, who resigned in December as CEO of the Knight Cancer Institute. Among the reasons Druker shared with OPB for his decision included low staff morale, a lack of trust in OHSU’s leaders and the organization’s cost-cutting measures, such as its decision to lay off more than 500 employees.  Leading OHSU during this turbulent time is Steve Stadum. The board of directors appointed him as interim president in November, marking his return to the organization which he first worked at more than 25 years ago. Stadum joins us to share his vision for OHSU and how he aims to navigate its internal and external challenges, including threats to federally funded research from the new Trump administration.  

A new study made national headlines, estimating that in the next three decades, around 42% of adults over the age of 55 will develop dementia. Allison Lindauer is an associate professor of neurology at the Oregon Alzheimer’s Disease Research Center at OHSU. She joins us to share what we know about dementia and what people can do to prevent it.

In this episode we talked to Neuroscientist Dr. Larry Sherman of OHSU about the upcoming Romance, Love Songs, and Neuroscience event coming up this valentines day. We also talked to the Wiggles, an internationally famous group, who will be in concert in Portland on June 5th for their Bouncing Balls Tour.

The fentanyl crisis has taken a toll on communities all across Oregon. It has also shined a light on the challenges frontline responders face when trying to get people help for substance use disorder, especially in rural areas and jails or prisons where treatment can be hard to obtain.   But a training program in addiction medicine offered by OHSU is providing help by sharing resources, best practices and collaborative problem solving on complex cases. While most of the people who enroll in the course, which is taught remotely, work in healthcare, it’s attracting growing interest among law enforcement. Enrollment overall in the training program has grown by nearly two-thirds in the past two years. Dan Hoover, an assistant professor of medicine and the director of the Extension for Community Health Outcomes addiction medicine program at OHSU, joins us for more details.

Animals such as grizzly bears and Arctic ground squirrels have evolved the ability to hibernate as a way to survive winter months of extreme cold. During hibernation, their core body temperatures drop and their heart rates and metabolic activities slow to conserve energy. They also consume less oxygen during this inactivity.    But what if you could make non-hibernating species – including humans - hibernate? How could you control hibernation as a therapy to help people recover from strokes or heart attacks, or administer it to astronauts to help them endure a yearslong trip to Mars? Scientists at Oregon Health & Science University have embarked on a first step to exploring these questions by inducing a state of hibernation in rats, which don’t normally hibernate. Joining us to discuss this research is Domenico Tupone, a research assistant professor of neurology at OHSU.

According to the CDC, more than 2 million people in the U.S. are infected with hepatitis C. The bloodborne illness attacks the liver and can lead to cancer or death if left untreated. Injection drug use is the leading risk factor for hepatitis C, which is also more prevalent in rural counties where diagnosis and treatment can be hard to come by, especially for people experiencing homelessness.  Scientists at Oregon Health and Science University demonstrated a new strategy that could significantly boost the diagnosis and successful treatment of hepatitis C in rural communities. In a recently published study, they showed that peers with lived experience in drug use were able to successfully enroll and facilitate treatment for people who tested positive for hepatitis C in six rural Oregon counties using telemedicine, which was seven times more effective than referrals to clinics for in-person treatment. Joining us to talk about the results and the role peer specialists can play to combat the spread of hepatitis C is Dr. Andrew Seaman, an associate professor of medicine at OHSU, the medical director of HIV and hepatitis C services at Central City Concern and head of substance use disorder programs at Better Life Partners in New England.  

Oregon Health & Science Institute's online training program is reaching more Oregon professionals in healthcare and law enforcement.

In this episode of the Becker's Healthcare Podcast, Dr. John Hunter, former CEO of OHSU and expert esophageal surgeon, discusses the evolving dynamics between healthcare executives and physicians in a post-pandemic world. From the rise of physician unionization to fostering sustainable work environments and aligning missions, Dr. Hunter shares valuable insights and advice for healthcare leaders striving to create meaningful change in their organizations and communities.

If you're an ASOPRS Member, Surgeon or Trainee and are interesting in hosting a podcast episode, please submit your idea by visiting: asoprs.memberclicks.net/podcast About the Guests: Dr. Roger A. Dailey, MD, FACS: He is a renowned ophthalmologist and faculty member at Oregon Health & Science University, specializing in oculoplastics. Dr. Dailey has a vast professional history, starting his residency in 1983, and has made significant contributions to the development of oculoplastic procedures and education. Dr. Jack Wobig, MD, MBA, FACS: A retired ophthalmologist with a rich legacy in oculoplastic and orbital surgery. Dr. Wobig was a key figure at OHSU and spent decades in private practice and teaching, contributing significantly to the field through his research and collaborations, most notably with Lester Jones. Dr. Andrew Harrison, MD: An oculoplastic and orbital surgeon at the University of Minnesota, Dr. Harrison is well-versed in advanced surgical techniques. He completed his fellowship with Dr. Wobig and Dr. Dailey and continues to advance the field through both his surgical practice and academic contributions. Episode Summary: In this engaging episode of the ASOPRS podcast, hosts Dr. Roger Dailey and Dr. Andrew Harrison are joined by the legendary Dr. Jack Wobig to delve into the rich history and evolution of oculoplastic surgery. The conversation hones in on Dr. Wobig's remarkable career, including his professional journey, collaborations with Lester Jones, and the innovative development of the Jones tube for lacrimal duct surgeries. This episode not only offers a window into the pioneers of oculoplastics but also provides valuable insights for future surgeons. Throughout the discussion, the guests highlight various milestones in the field of oculoplastics, emphasizing the importance of anatomical precision and collaboration in surgical innovations. The trio reminisces about shared experiences, with anecdotes that underscore the transformative impact of their mentors and colleagues. By examining the past and contemplating future challenges and opportunities, the episode paints a comprehensive picture of the field's trajectory. Insights into educational practices, the expanding global impact of Aesoppers, and the evolving dynamics of surgical training provide both a nostalgic and forward-looking view on the practice of oculoplastics. Key Takeaways: Historical Insights: Exploration of Dr. Jack Wobig's collaboration with Lester Jones in developing the Jones tube and its impact on lacrimal surgery. Evolution of ASOPRS: Discussion on the early days of ASOPRS, its formation, and Dr. Wobig's presidency, highlighting the challenges and growth in training and standards enforcement. Educational Influence: Reflections on the importance of international exposure and collaboration in shaping successful careers in oculoplastics. Retirement Advice: Dr. Wobig shares perspectives on retirement, the value of lifelong learning, and the fulfillment derived from a meaningful career and rich family life. Lifelong Relationships: Emphasis on the importance of maintaining connections with colleagues and fellows, fostering a family-like environment within the surgical community.

It’s been a few years, but we are here with an update on acromegaly, covering prevalence, diagnosis, traditional treatment, new therapies, and current gaps in understanding. Host Aaron Lohr talks again with Maria Fleseriu, MD, professor of medicine and professor of neurological surgery at Oregon Health & Science University School of Medicine and director of OHSU’s Pituitary Center. Dr. Fleseriu also serves on the Board of Directors of the Endocrine Society. Show notes are available at https://www.endocrine.org/podcast/enp94-update-on-acromegaly — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

From cable grafts to free muscle transfer, surgical treatments for facial paralysis are evolving quickly. In this episode of the Backtable ENT Podcast, Dr. Myriam Loyo Li, facial plastic surgeon at OHSU, joins guest host Dr. Shiayin Yang of Vanderbilt to discuss dynamic procedures for facial paralysis. --- This podcast is supported by: BackTable + ENT https://www.backtable.com/shows/ent --- SYNPOSIS First, the surgeons review workup of flaccid and non-flaccid (synkinetic) facial paralysis. Then, they review the principles of facial reanimation. Topics such as nerve graft selection and staged surgery are covered. Dr. Loyo Li explains her timelines for staged surgery and how patient characteristics affect her decision planning. Finally, the surgeons discuss free muscle transfer – an exciting new technique in the world of facial plastic surgery – to treat facial paralysis. --- TIMESTAMPS 00:00 - Introduction 02:48 - Evaluating and Managing Flaccid Facial Palsy 05:18 - Imaging and Treatment Pathways 07:16 - Nerve Grafting Techniques and Preferences 10:08 - Challenges and Innovations in Facial Reanimation 25:50 - Patient-Centered Approaches and Decision Making 37:30 - Evaluating Facial Nerve Recovery 43:25 - Timing and Criteria for Nerve Transfers 46:41 - Free Muscle Transfer Techniques 49:47 - Innovations in Cross Facial Nerve Grafts 01:06:04 - Exploring Free Strap Muscle Transfers 01:14:05 - The Future of Facial Reanimation --- RESOURCES Dr. Loyo Li's OHSU Profile: https://www.ohsu.edu/providers/myriam-loyoli-md-mcr Dr. Yang's Vanderbilt Profile: https://www.vanderbilthealth.com/doctors/yang-shiayin

Menopause can present a wide range of symptoms, from hot flashes and sleep disturbances to brain fog and loss of bone density. Though several safe and effective therapies are available, many patients still aren’t receiving the help they need. A new study from Oregon Health & Science University found that more than 60% of respondents with moderate to severe menopause symptoms weren’t receiving any treatment. The primary reason they reported not engaging in treatment was that their clinician hadn’t recommended it to them. Maria Rodriguez is a professor of obstetrics and gynecology at OHSU and the director of the university’s Center for Reproductive Health Equity. Sara Cichowski is the university’s vice chair of gynecology and an assistant professor of obstetrics and gynecology. They both join us to talk more about the barriers to accessing menopause care in Oregon.

In this episode, we speak with Dr. Eneida Nemecek, a pediatric oncologist specializing in bone marrow transplants and cellular therapies. Dr. Nemecek provides an in-depth look at the science behind these treatments, the process patients go through, and the challenges faced by both patients and caregivers. She emphasizes the importance of caregiver well-being, particularly sleep, and discusses a PCORI study on stress management for caregivers. The episode concludes with a rapid-fire Q&A session covering key terms and concepts in the field. This episode was supported by the Patient Centered Outcomes Research Institute (PCORI) and features these PCORI studies (Study #1 & Study #2) by Mark Laudenslager, PhD. Key Highlights: 1. Bone marrow transplant involves replacing a patient's immune system with a healthier one, either from a donor or the patient's own modified cells. 2. Caregiver quality of life, especially sleep, is crucial for patient outcomes in bone marrow transplant cases. 3. CAR-T therapy is a form of cellular therapy where white blood cells are engineered to attack specific targets, offering new treatment options for certain cancers. About our guest: Dr. Eneida Nemecek is a Professor of Pediatrics and Medical Oncology and Associate Director of Clinical Research at the Knight Cancer Institute-Oregon Health & Science University (OHSU) in Portland, Oregon. Native from Puerto Rico, she completed her Pediatric residency at Case Western Reserve University in Cleveland, OH and Pediatric Hematology/Oncology fellowship at the Fred Hutchinson Cancer Research Center in Seattle, Washington. She has a Master in Epidemiology and Clinical Research from the University of Washington and a Master in Healthcare Business Administration from OHSU. Dr. Nemecek is an established clinical researcher with over 20 years of experience in trials ranging from investigator-initiated early phase to large, multicenter studies funded by a variety of mechanisms.  Her research focuses on bone marrow and cellular therapies, experimental oncology therapeutics and health services research addressing disparities in access for underrepresented groups. She has served in leadership roles in steering committees for several national cooperative research groups.  She has also held elected leadership positions as director, trustee or committee chair in multiple professional organizations. The Your Cancer GPS™ platform is coming! Step-by-step subway maps that guide you through the entire cancer experience. Learn more here!⁠ Key Moments: At 14:40 “Sleep is healthy. If you are the one caregiver of a patient and you get sick because you're stressed and not getting enough rest, then you get affected and your patient gets affected too. It's a very important part of our health. Eat, sleep, get some time for yourself. Those are all things that just need to happen. The way that we're designing medicine today, sometimes we forget that the caregiver is kind of a patient. If we lose that person, we are in serious trouble. I can tell you multiple examples about when that has happened and how difficult it is for the medical team and for the family.” At 28:03 “I think it's really important to remind ourselves that the brain, our psychosocial life, is part of our health. I think sleep, exercise, diet studies, anything that can improve the life of people should be studied in a very organized setting, just like you study drugs, if we're going to do this well.” Disclaimer: All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only.  This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Mariah Hudson is a solo parent, a Senior Communications Specialist for OHSU, and has a Master's Degree in Economics. She is running for Portland City Council in District 2. https://www.mariahforportland.comhttps://www.instagram.com/mariahforportland?igsh=MW1pdzJvOGwwNTVodg==https://x.com/rationalinpdx/status/1795318576049795471?s=46https://x.com/rationalinpdx/status/1791349459030515776?s=46https://www.wweek.com/news/2023/02/01/they-left-portland-is-losing-some-of-its-biggest-fans/https://pdxscholar.library.pdx.edu/hrac_pub/45/

UNLOCKING ULTIMATE HEALTH & REDUCING CHRONIC DISEASE RISK with guest expert Dr. Casey MeansFeeling overwhelmed trying to reach optimal health? Are you done with fatigue, brain fog, anxiety, gut issues, and want to avoid or reverse type 2 diabetes while keeping cancer, heart disease and neurodegenerative disorders at bay?Dr. Casey Means joins me to break down all the mitochondrial dysfunction dragging you down while offering her top tips to boost your energy and improve your overall well-being as well as what biomarker tests to take and keep an eye on. Ready for 10 key insights to help you thrive? Let's dive in! In this episode, you'll learn about:Metabolic Health: How metabolic function (or dysfunction) affects overall health and longevity.Biomarkers: Using biomarkers such as fasting glucose and HDL to assess and improve metabolic health.Lifestyle Changes: Why adopting a whole foods, plant-based diet and cutting down on processed foods will give you the "Good Energy" you need.Metabolic Dysfunction: Links between metabolic issues and chronic diseases like heart disease, diabetes, and Alzheimer's.Healthcare Costs: Comparing treatment of symptoms versus preventative measures for chronic diseases.Our Healthcare System: Why it is failing you and how to take back power.Cellular Energy: Enhancing cellular energy through easy lifestyle adjustments.Artificial Light: How artificial light disrupts circadian rhythms and metabolic processes.Exercise: Benefits you may not know you don't know of various exercises, including HIIT, resistance training, and walking, for metabolic health.Environmental Toxins: Reducing exposure to environmental toxins through mindful product ABOUT OUR GUEST EXPERT:Casey Means, MD is a Stanford-trained physician, Chief Medical Officer and Co-founder of metabolic health company Levels, and Associate Editor of the International Journal of Disease Reversal and Prevention.She has held research positions at NIH, Stanford, NYU, OHSU and besides being an M.D. is also an AFMCP from the Institute for Functional Medicine.**************************************Control YOUR glucose regulation & learn with a CGM!Get your own CONTINUOUS GLUCOSE MONITOR (CGM) with these two favorites:ZOE -- Visit https://joinzoe.com/ and use code: SAMANTHA10 for 10% off**BONUS -- Zoe not only allows you to know your glucose levels, but also includes learning about your microbiome's good and bad gut bugs with a stool test AND a blood fat breakdown with the included blood test for triglycerides.NUTRISENSE -- Visit: https://bit.ly/NutrisenseCGM-SH25 -- for $25 off your CGM (or you can also use code: SAMANTHAHARRIS25). The app is super easy to navigate and understand PLUS you get a BONUS of free nutritionist guidance for the first month (and can add on more months after that for a fee).**************************************MORE FUN FROM SAMANTHA:Get my favorite, clean supplements, protein powders, and EWG-Verified clinically proven anti-aging skincare

Hardly a week goes by in the U.S. without a mass shooting, as the recent shooting at a high school in Georgia earlier this month reminds us of. In that tragedy, a 14-year-old student is suspected of killing two students and two teachers with a semiautomatic assault-style rifle which was legally purchased by his father. The National Rifle Association, along with some conservative lawmakers and the gun lobby argue that mental illness is to blame for mass shootings – not the easy access to firearms.  A new study by researchers at Oregon Health & Science University challenges that view. It compared the U.S. to 40 other countries for the prevalence of mental health disorders and deaths from firearms over a 20-year period, from 2000 to 2019. It found that death by firearms was 20 times greater in the U.S. compared to the other nations, while the prevalence of mental health disorders in the U.S. was similar. It also found that the firearm death rate decreased, on average, in those other countries whereas it increased sharply in the U.S. over that timeframe. Joining us to share details about the study is Archie Bleyer, a pediatric and young adult oncologist at OHSU. 

Hardly a week goes by in the U.S. without a mass shooting, as the recent shooting at a high school in Georgia earlier this month reminds us of. In that tragedy, a 14-year-old student is suspected of killing two students and two teachers with a semiautomatic assault-style rifle which was legally purchased by his father. The National Rifle Association, along with some conservative lawmakers and the gun lobby argue that mental illness is to blame for mass shootings – not the easy access to firearms.  A new study by researchers at Oregon Health & Science University challenges that view. It compared the U.S. to 40 other countries for the prevalence of mental health disorders and deaths from firearms over a 20-year period, from 2000 to 2019. It found, for example, that the firearm death rate was 11 times greater in the U.S. compared to the other nations while the prevalence of mental health disorders in the U.S. was similar. It also found that the firearm death rate in the U.S. had increased, whereas it declined among the other nations. Joining us to share details about the study is Archie Bleyer, a pediatric and young adult oncologist at OHSU.  Read on-air: The Great Salt Lick auction will take place this Saturday at 6 p.m. at the Churchill School in Baker City. Attendance is free.  

U.S. Surgeon General Dr. Vivek H. Murthy recently issued an advisory saying stress from parenting is a public health issue. The nation's doctor shared his concerns over the well-being of parents, noting overwhelming stressors affecting parents today – from financial pressures to worries around kids' health and safety. The advisory notes that nearly half of parents say most days their stress is overwhelming and more than 40% say they are so stressed they cannot function. Marlo McIlraith is an associate professor of pediatrics and a pediatrician at OHSU. She joins us to share more on what is causing more parents to be stressed today and ways she recommends they try to help deal with these emotions.

Join for the fifth episode in the Association of Out Surgeons and Allies (AOSA) series for a comprehensive discussion of what the general surgeon needs to know prior to operating on a patient who has previously undergone gender affirming surgery. Host:  Dan Scheese, MD Andrew Schlussel, DO, Colorectal and General Surgeon, Charlie Norwood VA Medical Center Guests: Dr. Megan Lane (She/her) megalane@med.umich.edu Dr. Lane is a plastic surgery resident at the University of Michigan who is planning on going into Gender Affirming Surgery and general reconstruction. She completed a research fellowship in the National Clinician Scholars Program and focused primarily on patient-reported outcomes in gender affirming surgery. Dr. Amy Suwanabol pasuwan@med.umich.edu Dr. Suwanabol is a colorectal surgeon at the University of Michigan and the Ann Arbor VA. She assists the gender affirming surgeons at the University of Michigan in performing robotic-assisted vaginoplasty. Her research focuses on optimizing quality of life among surgical patients and their families, surgeon well-being, and cancer survivorship. Dr. Monica Llado-Farrulla lladorfar@ohsu.edu Dr. Llado-Farrulla was born and raised in Puerto-Rico, completed general surgery residency followed by plastic surgery residency at Tulane and Penn, respectively. She pursued a year of training in advanced gender surgery and is now currently at OHSU. Her practice largely focuses on facial feminization, chest affirming surgeries, phalloplasty, autologous breast reconstruction, and limb salvage.  Learn more and get involved with AOSA: https://www.outsurgeons.org Twitter/X: @OutSurgeons Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

If you're an ASOPRS Member, Surgeon or Trainee and are interesting in hosting a podcast episode, please submit your idea by visiting: asoprs.memberclicks.net/podcast In the first of the TOP Surgical Battle Series, Dr. Natalie Homer (Stanford) moderates a debate between the frontalis sling (Dr. John Ng, OHSU) and frontalis muscle flap (Dr. Richard Allen, TOC Eye and Face) techniques for correction of myogenic ptosis. In this episode, Dr. John Ng advocates for the frontalis sling procedure, emphasizing its straightforward nature, time-tested effectiveness, and adaptability. Dr. Ng discusses the various materials used, including silicone and fascia lata, and the procedure's suitability for teaching and clinical practice. He addresses the potential for infection, material failure, and the cosmetic aspects of the procedure. Dr. Richard Allen alternatively defends the frontalis muscle flap procedure, making a compelling case for its efficiency and durability. He details his comprehensive technique, incorporating elements such as levator resection. He shares his experience on patient outcomes, complications, and long-term results with this procedure.  Key Takeaways: The frontalis sling procedure is known for its straightforward approach and adaptability, particularly useful in teaching environments and varying patient anatomies. A variety of materials can be used in the frontalis sling procedure, including silicone and fascia lata. Each material has its pros and cons, such as durability and infection risks. The frontalis muscle flap procedure can avoid the use of foreign materials, offering a potentially longer-lasting solution. The technique includes levator resection for optimal eyelid contour and function. Post-operative care and complication management, including lagophthalmos and dry eye, are critical regardless of the technique used. Both procedures have unique indications and may be chosen based on individual patient needs, anatomical considerations, and potential for future adjustments. Notable Quotes: “The advantage of the [frontalis] sling is…for teaching at a teaching institute. The anatomy and the procedure is a lot easier to teach and has a...shallower learning curve.” - Dr. John Ng “The beauty of a frontalis flap procedure is that you're making a single incision across the eyelid, at the eyelid crease.” - Dr. Richard Allen “I think that if you don't do it,…they're gonna find someone that does.”- Dr. Richard Allen “It's…representation of how the materials and techniques have evolved over time, balancing traditional methods with newer innovative practices.” (Regarding the frontalis muscle flap procedure) - Dr. John Ng

The birth of a baby is often celebrated as a joyful and natural process, but it can also be physically and emotionally traumatic. The Perinatal Trauma Clinic at Oregon Health & Science University is one of only a handful nationwide that aims to support parents who have experienced trauma around birth or pregnancy. Patients work with both mental and physical health care providers at the Center for Women’s Health to develop a plan that fits their personal circumstances.   Katie Au and Katherine Jorda are both associate professors of obstetrics and gynecology at OHSU. They co-direct the clinic and join us with more details about the care they provide.

What is a healthy diet and how much does it really matter that we try to eat one as we age?  That's the topic of this week's podcast with three amazing guests: Anna Pleet, Elizabeth Eckstrom, and Emily Johnston. Emily Johnston is a registered dietitian, nutrition researcher, and Assistant professor at NYU.  Anna Pleet is an internal medicine resident at Allegheny Health Network who has a collection of amazing YouTube videos on aging and the Mediterranean diet. Elizabeth Eckstrom is a geriatrician, professor of medicine at OHSU, and author of a new book, the Gift of Aging. I love this podcast as while we talk about the usual topics in a medical podcast, like the role of screening, energy balance, and evidence-based for specific diets, we also talk about what a Mediterranean diet actually looks like on a plate and pepper our guests with questions about their favorite meals to convince Alex and me to eat more like a Sardinian. Eric PS.  NEJM just published a great summary of diets summing up adherence to the Mediterranean diet and the following improved health outcomes: death from any cause, cardiovascular diseases, coronary heart disease, myocardial infarction, cancer, neurodegenerative diseases, and diabetes    

For many years now, medical schools around the country have ceased using live animals to perform procedures as part of the curriculum. But in a minority of surgical residencies, residents operate on animals – often pigs – to practice techniques to be used on human patients. Oregon Health & Science University is in that minority. For years, People for the Ethical Treatment of Animals has been waging a campaign to get OHSU’s OB/GYN residency program to stop using pigs for doctors in training to practice reproductive surgeries on. At the same time, the Physicians Committee for Responsible Medicine is asking the hospital to stop using the animals in all of its surgical residencies in all branches of the hospital.  OHSU declined to participate in this conversation, but Dr. Kerry Foley, a retired emergency medical doctor who volunteers for the Physicians Committee for Responsible Medicine, joins us to share her views on best practices for surgical training and why those do not include using animals. 

When autumn arrives, reminders typically start going out for people to get their annual flu shot. The vaccine changes each year, based on what strain of influenza is likely to be circulating then. Sometimes it’s a good match and other times, not so good. But what if you could get one vaccine that would confer lifetime protection against the flu and its ever-changing strains?  Scientists at Oregon Health & Science University are working on advancing that goal by developing a new way to deliver vaccines against flu viruses. The vaccines are delivered through a harmless virus that most people are exposed to at some point in their lives. The technology stimulates the body to release cells that attack the internal machinery of the harmful virus instead of its outer surface which can evolve to slip past immune defenses. Joining us to talk about this research is Jonah Sacha, a professor at OHSU and the chief of pathobiology at the Oregon National Primate Research Center.  

According to the Centers for Disease Control & Prevention, veterans have a 57% higher risk of suicide than the general population. But little is known about how that risk differs between men and women. In the first study of its kind, researchers at Oregon Health & Science University followed a group of veterans for roughly a year after a nonfatal suicide attempt. They found that the women who were surveyed reported more social rejection and lower levels of self-compassion than men, suggesting a higher risk of another attempt.  Lauren Denneson is a professor of psychiatry at OHSU and associate director of the Center to Improve Veteran Involvement in Care at the VA Portland Health Care System. She is the lead author of the study and joins us with more details. Note: If you’re a veteran in crisis or concerned about one, contact the Veterans Crisis Line to receive 24/7 confidential support. To reach responders, dial 988 then press 1, chat online at VeteransCrisisLine.net/Chat, or text 838255. If you or someone you know is struggling, you can call or text 988 to reach the suicide and crisis lifeline. Help is available 24 hours a day, seven days a week.

Today, Fei and Nick are joined by Dr. Molly Kornfield, previously REI fellow and now assistant professor of reproductive endocrinology and infertility at OHSU. She tells us all about hyperprolactinemia: how we diagnose it, evaluate it, and treat it!  Twitter: @creogsovercoff1 Instagram: @creogsovercoffee Facebook: www.facebook.com/creogsovercoffee Website: www.creogsovercoffee.com Patreon: www.patreon.com/creogsovercoffee You can find the OBG Project at: www.obgproject.com

For the past five years, Oregon’s Lines for Life has been running a youth program called Safe Social Spaces. Now an OHSU study published in the journal Psychiatric Services suggests the program may have prevented more than 160 suicide attempts since it began. The program uses social media to find youth struggling with suicidal ideation and provide support through the social media’s direct messaging systems. We hear more from Angie Nielsen, the nonprofit’s YouthLine assistant director of clinical operations who co-authored the study, and gen castle, a social media crisis intervention specialist.  If you or someone you know is struggling, you can call or text 9-8-8 to reach the suicide and crisis lifeline or contact the YouthLine.  Help is available 24 hours a day, 7 days a week.

It’s been two years since the Dobbs v. Jackson Women’s Health Supreme Court decision that overturned the constitutional right to an abortion in the U.S. Since then, 14 states have instituted full bans on the procedure. Now new research shows that states with these bans are seeing fewer residency applications from medical students. Katie Hansen is an administrative chief resident at Oregon Health & Science University. Ian Field is an OB/GYN and the program director for OHSU's OB/GYN residency program. They both join us to share the impact the Dobbs decision has had on schools, communities and healthcare.

Daniel Gibbs dedicated his career as a neurologist to the study of Alzheimer’s and care for patients living with the disease. Then he was diagnosed with Alzheimer’s himself. Gibbs says that early diagnosis has allowed him to slow the progression of the disease through diet, exercise and other treatment. A documentary based on the book he wrote about his experience, “Tattoo on my Brain,” is airing on June 22 at OHSU. Gibbs and his wife, Louis Seed, join us to talk about living with Alzheimer’s.

In this episode, Alan Condon, Editor-in-Chief at Becker's Healthcare, discusses Mount Sinai Health System appointing Vincent Tammaro as the new Executive Vice President and CFO, effective in October. He also provides updates on health system financial results nationwide and reports on OHSU's plan to lay off at least 500 employees.

The federal COVID-19 emergency declaration, which expanded Medicaid coverage, officially ended last spring. Since then, state agencies that oversee Medicaid have been updating their eligibility rosters and disenrolling patients who no longer qualify. While some patients were determined ineligible, the vast majority were disenrolled for administrative reasons such as incomplete applications, incorrect paperwork and missed renewal notices.   A recent study from Oregon Health & Science University found that Black and Hispanic patients were twice as likely to lose coverage for those reasons than white patients. Jane Zhu is an associate professor of medicine at OHSU and one of the study’s authors. She joins us with more details.

Join for the forth episode in the Association of Out Surgeons & Allies (AOSA) series for a discussion on gender affirming care and gender affirming surgery. Host: Dan Scheese, MD Andrew Schlussel, DO, Colorectal and General Surgeon, Charlie Norwood VA Medical Center Guests: 1. Dr. Megan Lane (She/her) megalane@med.umich.edu Dr. Lane is a Plastic Surgery resident at the University of Michigan who is planning on going into Gender Affirming Surgery and general reconstruction, she completed a research fellowship in the National Clinician Scholars Program and focused primarily on patient-reported outcomes in gender affirming surgery.  2. Dr. Scott Chaiet (he/him/his/himself) chaiet@surgery.wisc.edu Dr. Chaiet is double board certified by the American Board of Otolaryngology and the American Board of Facial Plastic & Reconstructive Surgery and is currently at the University of Wisconsin. His areas of expertise include rhinoplasty and facial gender surgery. He also practices reconstructive surgery including facial paralysis reanimation. His gender affirming practice includes all areas of the face and Adam's apple except for hair. 3. Dr. Amy Suwanabol  pasuwan@med.umich.edu Amy Suwanabol is a colorectal surgeon at the University of Michigan and the Ann Arbor VA. She assists the gender affirming surgeons at the University of Michigan in performing robotic assisted vaginoplasty. Her research focuses on optimizing quality of life among surgical patients and their families, surgeon well being, and cancer survivorship.   4. Dr. Monica Llado-Farrulla lladofar@ohsu.edu Dr. Llado-Farulla was born and raised in Puerto Rico, completed a residency in general surgery and then plastic surgery at Tulane and Penn, respectively. She pursued a year of training in advanced gender surgery and is now currently at OHSU, her practice largely focuses on facial feminization, chest affirming surgeries, phalloplasty, autologous breast reconstruction, and limb salvage.  5. Dr. Michele “Mike” Fascelli (he/him/his) FASCELM2@ccf.org Dr. Fascelli is a practicing reconstructive urologist at Cleveland Clinic.  He comppleted his urology training at the Cleveland Clinic in Ohio and then fellowship in urogenital gender affirming surgery with the urology team at OHSU with Dr. Llado-Farulla. He is now the Director of Urogenital Reconstruction and Co-Director of the Gender Affirming Surgery Program at Cleveland Clinic.  He is very committed to LGBTQIA+ urologic access and actively works to protect and expand care to the rainbow community, and to our trans and gender diverse patients.  His practice is currently focused on queer urologic health concerns and genital gender surgery (i.e. vaginoplasty, metoidioplasty and phalloplasty).     Learn more and get involved with AOSA: https://www.outsurgeons.org Twitter/X: @OutSurgeons   Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

A Food and Drug Administration advisory panel recently recommended the approval of a new blood test that can detect colon cancer. This comes at a time when more young people are getting diagnosed with colorectal cancer. Flavio Rocha is the physician-in-chief at OHSU’s Knight Cancer Institute. He joins us to share more on what this trend means and what new advances in technology can tell us. 

Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Connect with Melissa on Linkedin  DOT - Use the Code DENTALDIGEST for 10% off Dr. Dichter brings nearly 20 years of clinical, research and teaching experience — as a general practitioner and prosthodontist — to his position with Spear. He serves as an instructor in the Treating the Terminal Dentition and Fully Edentulous Patient seminar, in addition to multiple Spear Workshops. Dr. Dichter has served as a guest lecturer and clinical instructor at Oregon Health and Science University School of Dentistry, teaching occlusion and esthetics. He has been a Spear faculty member since the company's inception, as well as a contributing author for Spear Digest. He is passionate about education and is involved with multiple study groups in the U.S. and Canada. After earning his D.M.D. from OHSU in 1995, Dr. Dichter practiced general dentistry and eventually joined a startup practice in his hometown in coastal Oregon before moving to a practice in Portland. He brought 16 years of restorative dental experience into UCLA's world-renowned, full-time advanced prosthodontics residency, which he completed in 2014.